Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Magen-Darm » IBD (Crohn/Colitis) 20. Februar 2019
IBD (Crohn/Colitis)
Erweiterte Suche
Abklärungen / Diagnostik
News / Journalscreening
IBD (Crohn/Colitis)
Funktionelle Beschwerden
Peptisches Ulkus
Kongresse / Tagungen
Services / Tools
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 1707  vorhergehende Seite nächste Seite
   Artikel 1 - 20 / 34131  
Paraoxonase-1 and arylesterase levels in patients with ulcerative colitis.
Arab J Gastroenterol
Sahin M, Bobusoglu O, Yetim A, Ates F.
PMID: 30745012 [PubMed - as supplied by publisher]

Remission of diffuse ulcerative duodenitis in a patient with ulcerative colitis after infliximab therapy: a case study and review of the literature.
Intest Res
Choi YS, Kim JK, Kim WJ, Kim MJ.
PMID: 30739436 [PubMed - as supplied by publisher]

Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study.
Intest Res
Hibi T, Motoya S, Ashida T, Sai S, Sameshima Y, Nakamura S, Maemoto A, Nii M, Sullivan BA, Gasser RA, Suzuki Y.
PMID: 30739435 [PubMed - as supplied by publisher]

Indirect comparison of vedolizumab and adalimumab for biologic-naive patients with ulcerative colitis.
Scand J Gastroenterol
Dignass AU, Siegmund B, Goertz R, Schneidewind G, Fanter L.
PMID: 30735443 [PubMed - as supplied by publisher]

Predictive Value of Procalcitonin in Acute Severe Ulcerative Colitis: Not Quite PerfeCT?
Dig Dis Sci
Kim DW, An JM, Hong SP, Hahm KB.
PMID: 30734240 [PubMed - as supplied by publisher]

Golimumab in the treatment of ulcerative colitis.
Therap Adv Gastroenterol
Cunningham G, Samaan MA, Irving PM.
PMID: 30728858 [PubMed]

Short-Term and Long-Term Outcomes of Infliximab and Tacrolimus Treatment for Moderate to Severe Ulcerative Colitis: Retrospective Observational Study.
Kobe J Med Sci
Otsuka T, Ooi M, Tobimatsu K, Wakahara C, Watanabe D, Adachi S, Yasutomi E, Yamairi H, Ku Y, Yoshida M, Hoshi N, Kodama Y.
PMID: 30728340 [PubMed - in process]

Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study.
Intest Res
Park SK, Park SH, Eun CS, Seo GS, Im JP, Kim TO, Park DI.
PMID: 30727712 [PubMed - as supplied by publisher]

Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in 2 Clinical Trials.
J Crohns Colitis
Hanauer S, Sandborn WJ, Colombel JF, Vermeire S, Petersson J, Kligys K, Zhou Q, Lazar A, Reinisch W.
PMID: 30726897 [PubMed - as supplied by publisher]

Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus.
Dig Dis
Danese S, Allez M, van Bodegraven AA, Dotan I, Gisbert JP, Hart A, Lakatos PL, Magro F, Peyrin-Biroulet L, Schreiber S, Tarabar D, Vavricka S, Halfvarson J, Vermeire S.
PMID: 30726845 [PubMed - as supplied by publisher]

A simplified definition of histologic improvement in ulcerative colitis and its association with disease outcomes up to 30 weeks from initiation of therapy: Post-hoc analysis of three clinical trials.
J Crohns Colitis
Li K, Strauss R, Marano C, Greenbaum LE, Friedman JR, Peyrin-Biroulet L, Brodmerkel C, De Hertogh G.
PMID: 30721964 [PubMed - as supplied by publisher]

The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Astó E, Méndez I, Audivert S, Farran-Codina A, Espadaler J.
PMID: 30704039 [PubMed - in process]

Vedolizumab Trough Levels and Histological Healing During Maintenance Therapy in Ulcerative Colitis.
J Crohns Colitis
Pouillon L, Rousseau H, Busby-Venner H, De Carvalho Bittencourt M, Choukour M, Gauchotte G, Zallot C, Danese S, Baumann C, Peyrin-Biroulet L.
PMID: 30698684 [PubMed - as supplied by publisher]

High-intensity interval training and moderate-intensity continuous training in adults with Crohn's disease: a pilot randomised controlled trial.
BMC Gastroenterol
Tew GA, Leighton D, Carpenter R, Anderson S, Langmead L, Ramage J, Faulkner J, Coleman E, Fairhurst C, Seed M, Bottoms L.
PMID: 30696423 [PubMed - indexed for MEDLINE]

Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Am J Gastroenterol
Battat R, Duijvestein M, Guizzetti L, Choudhary D, Boland BS, Dulai PS, Parker CE, Nguyen TM, Singh S, Casteele NV, Pai RK, Feagan BG, Sandborn WJ, Jairath V.
PMID: 30694863 [PubMed - as supplied by publisher]

Validation of a novel integral disease index for evaluating the grade of activity in Mexican patients with ulcerative colitis: A prospective cohort study.
Rev Gastroenterol Mex
Yamamoto-Furusho JK, Bozada-Gutiérrez KE, Sánchez-Rodríguez A, Bojalil-Romano F, Barreto-Zuñiga R, Martínez-Benitez B.
PMID: 30679027 [PubMed - as supplied by publisher]

A new opportunity for innovative inflammatory bowel disease research: the moderate-to-severe ulcerative colitis in Korea (MOSAIK) cohort study.
Intest Res
Lee CK, Lee KM, Park DI, Jung SA, Jeen YT, Park YS, Kim HJ.
PMID: 30678443 [PubMed]

Impact of Modern Drug Therapy on Surgery: Ulcerative Colitis.
Visc Med
Kuehn F, Hodin RA.
PMID: 30675487 [PubMed]

Prevalence of cytomegalovirus infection in patients with ulcerative colitis: a prospective cross-sectional study in Tehran, Iran.
Iran J Microbiol
Yadegarynia D, Tehrani S, Roohi M, Gachkar L, Nadji SA, Hashemi M, Molanaei S.
PMID: 30675331 [PubMed]

Effects of synbiotic therapy in mild-to-moderately active ulcerative colitis: A randomized placebo-controlled study.
Turk J Gastroenterol
Kamarl, Akal Y, Ak.
PMID: 30666969 [PubMed - as supplied by publisher]

   Artikel 1 - 20 / 34131    Seite 1 von 1707  vorhergehende Seite nächste Seite

Rect Bottom
Adserver Footer



Das Fachportal für Eisenmangel >>


Sky right 1